Clinical course of colorectal cancer in patients with ulcerative colitis. 2011

Daijiro Higashi, and Kitaro Futami, and Yukiko Ishibashi, and Yuji Egawa, and Takafumi Maekawa, and Toshiyuki Matsui, and Akinori Iwashita, and Masahide Kuroki
Department of Surgery, Fukuoka University Chikushi Hospital, 1-1-1 Zokumyoin, Chikusino-shi, Fukuoka 818-8502, Japan. daijiro@fukuoka-u.ac.jp

BACKGROUND Colorectal cancer that develops as a complication of ulcerative colitis (UC) is a serious problem that affects the patient's prognosis. Such cancer is characterized by development at an early age, a high incidence of multiple tumors, poorly differentiated carcinoma and mucinous carcinoma. Special attention should therefore be paid to the diagnosis and treatment of such cancer. METHODS One hundred and seventy-four patients with UC underwent surgery in our Department between July of 1985 and December of 2009. Of these, 22 had concomitant colorectal cancer. We performed a retrospective study to investigate these patients. RESULTS The incidence of colorectal cancer as a complication of UC was 12.6%. The male:female ratio was 14:8, and the average age at surgery was 54.6 (32-79) years. In addition, when examining the lesion type of UC, it was revealed that the total colitis type accounted for 77.3% of colorectal cancer cases in UC patients. Regarding the site of development of colorectal cancer, 14 out of the 22 patients had cancer in the distal end. The average period from the development of UC to the diagnosis of colorectal cancer was 14.7 (0.6-40.5) years. The cumulative incidence rates over 10 and 20 years were 5.1% and 17.5%, respectively. Histologically, poorly differentiated adenocarcinoma and mucinous carcinoma were confirmed in 38.1% of the patients, and dysplasia was also confirmed in 53.8%. In addition, multiple tumors were confirmed at a rate as high as 27.3%. Cancer detection through surveillance has increased, and colorectal cancer was detected in 13 out of the 22 patients by routine surveillance. In cases where cancer was detected by surveillance colonoscopy, 46.2% of lesions were early cancer. We therefore consider that surveillance is useful. However, we experienced a case that could not be diagnosed by endoscopy that was successfully diagnosed by fluoroscopy. The case was noted to have stricture. CONCLUSIONS The cumulative incidence rates over 10 and 20 years were 5.1% and 17.5%, respectively. Since the average period from the onset of UC to the diagnosis of colorectal cancer was 14.7 years, routine surveillance examinations are necessary for patients with a history of UC of at least 10 years. In addition, patients with strictures must be examined using both colonoscopy and fluoroscopy because diagnosis with colonoscopy alone may be inadequate.

UI MeSH Term Description Entries
D007410 Intestinal Diseases Pathological processes in any segment of the INTESTINE from DUODENUM to RECTUM. Disease, Intestinal,Diseases, Intestinal,Intestinal Disease
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002288 Adenocarcinoma, Mucinous An adenocarcinoma producing mucin in significant amounts. (From Dorland, 27th ed) Carcinoma, Colloid,Carcinoma, Mucinous,Adenocarcinomas, Mucinous,Carcinomas, Colloid,Carcinomas, Mucinous,Colloid Carcinoma,Colloid Carcinomas,Mucinous Adenocarcinoma,Mucinous Adenocarcinomas,Mucinous Carcinoma,Mucinous Carcinomas
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D003082 Colectomy Surgical resection of a portion of or the entire colon. Hemicolectomy,Large Bowel Resection,Colectomies,Hemicolectomies,Large Bowel Resections,Resection, Large Bowel,Resections, Large Bowel
D003093 Colitis, Ulcerative Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN. Colitis Gravis,Idiopathic Proctocolitis,Inflammatory Bowel Disease, Ulcerative Colitis Type,Ulcerative Colitis
D003113 Colonoscopy Endoscopic examination, therapy or surgery of the luminal surface of the colon. Colonoscopic Surgical Procedures,Surgical Procedures, Colonoscopic,Colonoscopic Surgery,Surgery, Colonoscopic,Colonoscopic Surgeries,Colonoscopic Surgical Procedure,Colonoscopies,Procedure, Colonoscopic Surgical,Procedures, Colonoscopic Surgical,Surgeries, Colonoscopic,Surgical Procedure, Colonoscopic
D003251 Constriction, Pathologic The condition of an anatomical structure's being constricted beyond normal dimensions. Stenosis,Stricture,Constriction, Pathological,Pathologic Constriction,Constrictions, Pathologic,Pathologic Constrictions,Pathological Constriction,Stenoses,Strictures
D004198 Disease Susceptibility A constitution or condition of the body which makes the tissues react in special ways to certain extrinsic stimuli and thus tends to make the individual more than usually susceptible to certain diseases. Diathesis,Susceptibility, Disease,Diatheses,Disease Susceptibilities,Susceptibilities, Disease

Related Publications

Daijiro Higashi, and Kitaro Futami, and Yukiko Ishibashi, and Yuji Egawa, and Takafumi Maekawa, and Toshiyuki Matsui, and Akinori Iwashita, and Masahide Kuroki
July 2006, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
Daijiro Higashi, and Kitaro Futami, and Yukiko Ishibashi, and Yuji Egawa, and Takafumi Maekawa, and Toshiyuki Matsui, and Akinori Iwashita, and Masahide Kuroki
December 1988, Gastroenterology,
Daijiro Higashi, and Kitaro Futami, and Yukiko Ishibashi, and Yuji Egawa, and Takafumi Maekawa, and Toshiyuki Matsui, and Akinori Iwashita, and Masahide Kuroki
May 1994, The British journal of surgery,
Daijiro Higashi, and Kitaro Futami, and Yukiko Ishibashi, and Yuji Egawa, and Takafumi Maekawa, and Toshiyuki Matsui, and Akinori Iwashita, and Masahide Kuroki
January 2018, Best practice & research. Clinical gastroenterology,
Daijiro Higashi, and Kitaro Futami, and Yukiko Ishibashi, and Yuji Egawa, and Takafumi Maekawa, and Toshiyuki Matsui, and Akinori Iwashita, and Masahide Kuroki
March 2020, Zhonghua yi xue za zhi,
Daijiro Higashi, and Kitaro Futami, and Yukiko Ishibashi, and Yuji Egawa, and Takafumi Maekawa, and Toshiyuki Matsui, and Akinori Iwashita, and Masahide Kuroki
December 2017, Journal of digestive diseases,
Daijiro Higashi, and Kitaro Futami, and Yukiko Ishibashi, and Yuji Egawa, and Takafumi Maekawa, and Toshiyuki Matsui, and Akinori Iwashita, and Masahide Kuroki
March 1984, Gut,
Daijiro Higashi, and Kitaro Futami, and Yukiko Ishibashi, and Yuji Egawa, and Takafumi Maekawa, and Toshiyuki Matsui, and Akinori Iwashita, and Masahide Kuroki
July 2011, Anticancer research,
Daijiro Higashi, and Kitaro Futami, and Yukiko Ishibashi, and Yuji Egawa, and Takafumi Maekawa, and Toshiyuki Matsui, and Akinori Iwashita, and Masahide Kuroki
February 2015, Digestive diseases and sciences,
Daijiro Higashi, and Kitaro Futami, and Yukiko Ishibashi, and Yuji Egawa, and Takafumi Maekawa, and Toshiyuki Matsui, and Akinori Iwashita, and Masahide Kuroki
August 2020, Journal of gastroenterology and hepatology,
Copied contents to your clipboard!